CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 104 enrolled
Drug / intervention
Acupuncturedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01305811
NCT01305811Phase 2Completed
CompareCT.gov

Acupuncture in the Treatment of Gulf War Illness

New England School of Acupuncture·interventional·Posted Mar 1, 2011·Updated Jun 15, 2015

In Brief

A Phase 2 clinical trial evaluating Acupuncture for Persian Gulf Syndrome. Completed, enrolled 104 participants across 1 site.

Detailed Summary

This unblinded Phase II clinical trial tested the effects of individualized acupuncture treatments offered in extant acupuncture practices in the community; practitioners had at least 5 years of experience plus additional training provided by the study. Veterans with diagnosed symptoms of Gulf War Illness were randomized to either six months of biweekly acupuncture treatments (group 1, n=52) or 2 months of waitlist followed by weekly acupuncture treatments (group 2, n=52). Measurements were taken at baseline, 2, 4 and 6 months. The primary outcome is the SF-36 physical component scale score (SF-36P).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPersian Gulf Syndrome
CountriesUnited States
CollaboratorsUnited States Department of Defense

Timeline

Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMar 1, 2011
Enrollment StartJul 1, 2009
Primary CompletionJan 1, 2013
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 15.3 years ago

Interventions

Acupuncturedevice

Sterile insertive needles are applied by licensed, experienced practitioners.